---
title: "1区9+：揭示AKR1C3通过抑制铁死亡介导食管癌放疗耐受的全新机制"
date: 2025-09-04T10:32:33Z
draft: ["false"]
tags: [
  "fetched",
  "i生信"
]
categories: ["Acdemic"]
---
1区9+：揭示AKR1C3通过抑制铁死亡介导食管癌放疗耐受的全新机制 by i生信
------
<div><section><span leaf=""><mp-common-profile data-pluginname="mpprofile" data-nickname="i生信" data-from="2" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/uR5O2f9J2LtRZ4v6Ribf11IMcgNvC4HV26K1M6kC6sfyJGht49VsdVZGTIgicthMmftjjW2H7JvvvM0cic81uFy5w/0?wx_fmt=png" data-signature="专注生物分析最前沿，定期为大家解读最新高分经典生信文章，为大家提供生信分析思路和套路，方便大家短平快发SCI。" data-id="Mzg5MjE5Mjc0Mw==" data-is_biz_ban="0"></mp-common-profile></span></section><section><span leaf="">今天介绍一项发表在《Cell Death &amp; Disease》上的研究：AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5，即：AKR1C3通过抑制TRIM21介导的HSPA5泛素化，抑制铁死亡，增强食管腺癌的放射耐受性。</span></section><section><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibIyBwIVAq7f627PXjibz8oicaonaTOt2HmSJ2f4Wd2wcR3FnW2X8cyYAQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.5341040462427745" data-type="png" data-w="865" data-imgfileid="100024290" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibIyBwIVAq7f627PXjibz8oicaonaTOt2HmSJ2f4Wd2wcR3FnW2X8cyYAQ/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">研究背景</span></span></section><section><span leaf="">食管腺癌（EAC）是高收入国家食管癌的主要亚型，放疗耐受是其预后不良的关键因素之一。尽管在诊断和治疗方面取得了显著进展，但EAC患者的全球5年生存率仍低于15%。</span></section><section><span leaf=""><span textstyle="">研究结果</span></span></section><section><span leaf=""><span textstyle="">放疗耐受EAC细胞系的建立</span></span></section><section><span leaf="">作者选择了EAC细胞系--OE33细胞系，通过25次2Gy伽马射线照射，建立了放疗耐受的OE33R。通过<span textstyle="">集落形成</span>验证了OE33R的放疗耐受能力，结果显示<span textstyle="">OE33R的存活分数显著高于亲本细胞系OE33P</span>。<span textstyle="">多靶单击模型</span>表明，<span textstyle="">OE33R的D</span><span textstyle="">0</span><span textstyle="">和D</span><span textstyle="">q</span><span textstyle="">值显著高于OE33P</span>，这表明<span textstyle="">OE33R的放疗耐受能力增强</span>。</span></section><section><span leaf=""><span textstyle="">RNA测序与数据分析</span></span></section><section><span leaf="">对OE33P和OE33R进行<span textstyle="">RNA测序分析，发现AKR1C3在OE33R中显著上调</span>。进一步分析TCGA食管癌队列数据，发现只有AKR1C3在肿瘤组织中表达上调，与RNA测序结果一致。通过qRT-PCR和Westernblot验证了<span textstyle="">AKR1C3在OE33R中的高表达</span>。</span></section><section><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibTMPafmumnfia6RicRicxLIeBjkOpul8qy98Ve3JF8VS6aQPEUcfLxHABQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.7132947976878613" data-type="png" data-w="865" data-imgfileid="100024291" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibTMPafmumnfia6RicRicxLIeBjkOpul8qy98Ve3JF8VS6aQPEUcfLxHABQ/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">单细胞RNA测序分析</span></span></section><section><span leaf="">对4例治疗初治EAC患者的肿瘤组织进行单细胞RNA测序分析，UMAP图显示共计注释了14个细胞群。<span textstyle="">AKR1C3主要表达在（增殖）癌细胞中，而在正常上皮细胞中表达较低</span>，这与GEO和TCGA数据一致。</span></section><section><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibbQWp0EUqKIwge9SKBHtvO7rvN6M6dOicpK8MicXWiay6VCm7XgB45F4Qg/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.3352601156069364" data-type="png" data-w="865" data-imgfileid="100024292" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibbQWp0EUqKIwge9SKBHtvO7rvN6M6dOicpK8MicXWiay6VCm7XgB45F4Qg/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">AKR1C3与EAC患者治疗反应和预后的关系</span></span></section><section><span leaf="">研究者收集了8例接受CROSS治疗的EAC患者的配对样本，发现<span textstyle="">AKR1C3水平在主要反应组中经新辅助治疗后显著下调，而在次要反应组中表达水平较高</span>。分析TCGA数据发现，<span textstyle="">AKR1C3在食管癌患者的肿瘤组织中表达上调</span>。进一步分析128例EAC活检样本的RNA测序数据，发现<span textstyle="">AKR1C3高表达组的预后趋势优于低表达组</span>。TCGA-EAC数据分析也显示出类似的趋势。</span></section><section><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibHxCSIEpDwX9SuUnes4RKeTkaP8EDKT0jicy6AVlibYGtDBzSMYhLmbvg/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.7213872832369942" data-type="png" data-w="865" data-imgfileid="100024293" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibHxCSIEpDwX9SuUnes4RKeTkaP8EDKT0jicy6AVlibYGtDBzSMYhLmbvg/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">AKR1C3增强EAC细胞的放疗耐受</span></span></section><section><span leaf="">通过构建<span textstyle="">OE33VEC（对照）/OE33AKR1C3（过表达）</span>和<span textstyle="">SKGT-4shNT（对照）/SKGT-4shAKR1C3（敲低）模</span>型，发现<span textstyle="">OE33AKR1C3在4Gy和6Gy放疗下的存活率高于OE33VEC，而SKGT-4shAKR1C3的存活率低于SKGT-4shNT</span>。免疫荧光和Westernblot检测γH2AX表明，<span textstyle="">OE33AKR1C3和OE33R在放疗后的DNA损伤较少，而SKGT-4shAKR1C3的DNA损伤较多</span>。彗星实验也证实了这一结果。此外，流式细胞术检测发现，放疗后72小时，OE33AKR1C3的死细胞数量显著少于OE33VEC，而SKGT-4shAKR1C3的死细胞数量多于SKGT-4shNT。</span></section><section><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibdibGmytlyO5v8RFickeQnTZuEuVZHEe9FymnkNoicJDNxnr4fyz5rxtYA/640?wx_fmt=png&amp;from=appmsg" data-ratio="1.299421965317919" data-type="png" data-w="865" data-imgfileid="100024295" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibdibGmytlyO5v8RFickeQnTZuEuVZHEe9FymnkNoicJDNxnr4fyz5rxtYA/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">AKR1C3与铁死亡的关系</span></span></section><section><span leaf="">KEGG通路分析显示，基于OE33P/R的差异表达基因（DEGs），<span textstyle="">铁死亡相关基因显著富集</span>。进一步分析发现，<span textstyle="">AKR1C3与铁死亡抑制因子的重叠基因为AKR1C3、AKR1C2、AKR1C1、ADAMTS13和PANX2</span>。在TCGA-EAC队列中，排除接受放疗的患者后，<span textstyle="">铁死亡在AKR1C3高表达组中显著富集</span>。单细胞RNA测序数据分析也显示，<span textstyle="">铁死亡和谷胱甘肽代谢途径显著富集。</span></span></section><section><span leaf=""><img data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAib5oFDvI97ibLKBoOc8RM24icqYJwB01mWCkW5v8rrVut8KJsC1GHtWnGA/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.9317919075144508" data-type="png" data-w="865" data-imgfileid="100024296" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAib5oFDvI97ibLKBoOc8RM24icqYJwB01mWCkW5v8rrVut8KJsC1GHtWnGA/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">AKR1C3调控氧化还原平衡并抑制EAC细胞中的铁死亡</span></span></section><section><span leaf="">谷胱甘肽（GSH）是主要的细胞抗氧化剂，有助于维持氧化还原平衡，中和活性氧（ROS）并防止氧化应激和铁死亡。作者发现AKR1C3可能通过促进NADPH生成，为GSH合成提供必要的物质，从而有助于细胞氧化还原平衡。使用铁死亡诱导剂Erastin处理EAC细胞系，发现AKR1C3过表达的细胞对Erastin更具耐药性。流式细胞术检测发现，AKR1C3过表达的细胞在Erastin处理后的脂质ROS水平较低，表明<span textstyle="">AKR1C3可防止EAC细胞发生脂质过氧化，从而抑制铁死亡</span>。透射电子显微镜（TEM）观察到，OE33R和OE33AKR1C3在放疗后的线粒体形态变化较小，而<span textstyle="">OE33P和SKGT-4shAKR1C3的线粒体形态变化显著，这与典型的铁死亡形态一致</span>。</span></section><section><span leaf=""><span textstyle="">AKR1C3通过抑制TRIM21介导的HSPA5泛素化来抑制铁死亡</span></span></section><section><span leaf="">通过在<span textstyle="">OE33 AKR1C3和SKGT-4细胞系中进行co-IP和蛋白质组学分析</span>，并<span textstyle="">与FerrDb2数据库中的铁死亡抑制因子取交集</span>，发现<span textstyle="">AKR1C3可能与HSPA5相互作用</span>，而HSPA5/GPX4轴在抑制铁死亡中起负向调节作用。免疫共沉淀实验和免疫荧光实验验证了AKR1C3与HSPA5的相互作用。</span></section><section><span leaf="">鉴于RNA-seq数据没有显示HSPA5 mRNA水平的显着差异，<span textstyle="">推测转录后修饰可能有助于这种调节</span>。经研究发现，<span textstyle="">AKR1C3可能通过减少TRIM21介导的HSPA5泛素化来稳定HSPA5/GPX4轴，从而抑制铁死亡</span>。</span></section><section><span leaf=""><img data-imgfileid="100024297" data-ratio="1.323699421965318" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibOHGia46nqugRhvVnpfzA5kOSFf5cb4lYzFFDmcNSEzZX697icO2NFOxg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="865" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAibOHGia46nqugRhvVnpfzA5kOSFf5cb4lYzFFDmcNSEzZX697icO2NFOxg/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">AKR1C3抑制剂使EACPDOs对放疗重新敏感</span></span></section><section><span leaf="">从建立的PDO队列中选择了一个AKR1C3表达高的PDO进行实验。结果显示，<span textstyle="">AKR1C3抑制剂MPA单独使用对PDOs的大小、活力或存活率影响较小，但与放疗联合使用时，可显著抑制PDOs的生长速度和存活率</span>，表明<span textstyle="">MPA可使EAC PDOs对放疗重新敏感</span>。</span></section><section><span leaf=""><img data-imgfileid="100024298" data-ratio="0.684393063583815" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAib0Feex1K1ahic7CuiaiaftyZcmrsSNSoMS7TzicEj7FuelFGKjZhIPqgic4Q/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="865" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LuVYp9lml7Llm5DOzUrdUAib0Feex1K1ahic7CuiaiaftyZcmrsSNSoMS7TzicEj7FuelFGKjZhIPqgic4Q/640?wx_fmt=png&amp;from=appmsg"></span><span leaf=""><span textstyle="">结论</span></span></section><section><span leaf="">本研究揭示了AKR1C3在EAC放疗耐受中的关键作用，其通过抑制铁死亡来增强EAC细胞的放疗耐受。<span textstyle="">AKR1C3通过与HSPA5结合，减少TRIM21介导的HSPA5泛素化，稳定HSPA5/GPX4轴，从而抑制铁死亡</span>。此外，<span textstyle="">AKR1C3抑制剂MPA可使EAC PDOs对放疗重新敏感</span>，为克服EAC放疗耐受提供了潜在的治疗策略。</span></section><section data-pm-slice="3 1 []"><span data-pm-slice="0 0 []"><span leaf="" data-pm-slice='1 1 ["para",{"tagName":"section","attributes":{},"namespaceURI":"http://www.w3.org/1999/xhtml"},"para",{"tagName":"section","attributes":{"style":"text-align: center;"},"namespaceURI":"http://www.w3.org/1999/xhtml"},"node",{"tagName":"span","attributes":{"style":"color: rgba(0, 0, 0, 0.9);font-family: 楷体;font-size: 17px;font-style: normal;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 700;letter-spacing: 0.544px;orphans: 2;text-indent: 0px;text-transform: none;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;background-color: rgb(255, 255, 255);text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;float: none;display: inline !important;","data-pm-slice":"0 0 []"},"namespaceURI":"http://www.w3.org/1999/xhtml"}]'><span textstyle="">课题和文章思路请联系Bruin@解颐生物,扫码备注：科研合作</span></span></span></section><section nodeleaf=""><img data-imgfileid="100024048" data-ratio="0.9972826086956522" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LvtXZ7iaN0VhuU9X9EC1Fr7G26fwyxibL3iaOBxuOBfMSCFNx5JUTsXztibMOL6TaX4SHJbyP5dN8fDiaQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="368" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uR5O2f9J2LvtXZ7iaN0VhuU9X9EC1Fr7G26fwyxibL3iaOBxuOBfMSCFNx5JUTsXztibMOL6TaX4SHJbyP5dN8fDiaQ/640?wx_fmt=png&amp;from=appmsg"></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/N0OPOpK432ZnDtuD6ijGMw",target="_blank" rel="noopener noreferrer">原文链接</a>
